Valuation Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:24 2025-12-09 am EST			5-day change	1st Jan Change
106.82 ^CHF	+0.17%		+0.58%	+20.43%

12:12pm	European Equities Close Mostly Lower in Tuesday Trading; European Commission Probes Google for Competition Violations	MT
10:19am	Novartis Says 1 in 4 Breast Cancer Patients Treated With Kisqali Progression-Free Beyond 4 Years	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	215,322	196,458	194,448	207,167	195,514	253,214	-	-
Change	-	-8.76%	-1.02%	6.54%	-5.62%	29.51%	-	-
Enterprise Value (EV) ¹	239,822	204,649	203,482	219,178	213,458	273,162	277,382	273,403
Change	-	-14.67%	-0.57%	7.71%	-2.61%	27.97%	1.55%	-1.43%
P/E ratio	26.7x	8.2x	28.3x	14.1x	16.5x	18.2x	18.1x	16.7x
PBR	3.78x	2.9x	3.23x	4.41x	4.52x	5.71x	5.19x	4.79x
PEG	-	0x	-0.4x	0x	-1x	0.8x	21.08x	2.09x
Capitalization / Revenue	4.43x	3.81x	3.85x	4.56x	3.89x	4.57x	4.47x	4.29x
EV / Revenue	4.93x	3.96x	4.03x	4.82x	4.24x	4.93x	4.9x	4.63x
EV / EBITDA	14.2x	11.2x	10.9x	12.2x	10.2x	11.6x	11.8x	10.9x
EV / EBIT	15.6x	12.3x	12.2x	13.4x	10.9x	12.5x	12.8x	11.8x
EV / FCF	20.5x	15.4x	17x	16.6x	13.1x	19.2x	18.5x	17.2x
FCF Yield	4.87%	6.49%	5.87%	6.01%	7.61%	5.21%	5.41%	5.83%
Dividend per Share ²	3.375	3.36	3.5	3.823	3.856	4.086	4.251	4.453
Rate of return	3.57%	3.83%	3.87%	3.79%	3.94%	3.1%	3.22%	3.37%
EPS ²	3.55	10.71	3.19	7.15	5.92	7.243	7.306	7.889
Distribution rate	95.1%	31.4%	110%	53.5%	65.1%	56.4%	58.2%	56.5%
Net sales ¹	48,659	51,626	50,545	45,440	50,317	55,377	56,643	59,033
EBITDA ¹	16,845	18,246	18,613	17,937	21,006	23,564	23,587	25,161
EBIT ¹	15,416	16,588	16,665	16,372	19,494	21,872	21,754	23,092
Net income ¹	8,072	24,021	6,955	14,854	11,939	14,366	14,270	15,128
Net Debt ¹	24,500	8,191	9,034	12,011	17,944	19,947	24,168	20,188
Reference price ²	94.67	87.82	90.40	100.79	97.79	131.97	131.97	131.97
Nbr of stocks (in thousands)	2,274,506	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	-	-
Announcement Date	1/26/21	2/2/22	2/1/23	1/31/24	1/31/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NOVARTIS AG	18.22x	4.93x	11.59x	3.1%	253B
ELI LILLY AND COMPANY	43.61x	14.44x	32.05x	0.59%	893B
JOHNSON & JOHNSON	19.24x	5.4x	14.95x	2.56%	486B
ABBVIE INC.	52.12x	7.39x	17.51x	2.92%	394B
ROCHE HOLDING AG	18.44x	4.63x	11.59x	3.11%	336B
ASTRAZENECA PLC	27.22x	5.16x	15.3x	1.78%	280B
MERCK & CO., INC.	12.78x	4.18x	8.94x	3.27%	246B
NOVO NORDISK A/S	12.97x	4.66x	9.64x	3.89%	207B
AMGEN INC.	24.54x	5.99x	10.29x	2.97%	173B
GILEAD SCIENCES, INC.	17.68x	5.58x	10.21x	2.73%	150B
Average	24.68x	6.24x	14.21x	2.69%	341.87B
Weighted average by Cap.	29.26x	7.77x	17.97x	2.28%